Education
About Us
Working with TipRanks
Follow Us
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
PCRX Analyst Ratings
Hold
3 Buy
4 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PCRX Stock 12 Month Forecast
Average Price Target
$35.50
▲(37.38%Upside)
| Highest Price Target$65.00 | Average Price Target$35.50 | Lowest Price Target$24.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$27
Hold
4.49%
Upside
Reiterated
05/16/25
Pacira Pharmaceuticals shows potential with strong gross margins and positive earnings call guidance. However, profitability challenges and high leverage are significant risks. Technical indicators suggest moderate short-term momentum, but valuation remains a concern with a negative P/E ratio. Strategic initiatives could drive growth, but operational efficiencies need improvement.
J.P. Morgan
$21→$24
Sell
-7.12%
Downside
Reiterated
05/16/25
Truist Financial
―
Hold
―
Reiterated
05/09/25
Needham
$32→$30
Buy
16.10%
Upside
Reiterated
05/09/25
RBC Capital
$26
Hold
0.62%
Upside
Reiterated
05/08/25
Jefferies
$44
Buy
70.28%
Upside
Reiterated
04/08/25
H.C. Wainwright
$48→$65
Buy
151.55%
Upside
Reiterated
04/08/25
Raymond James
―
Hold
―
Reiterated
04/08/25
Barclays
$24
Hold
-7.12%
Downside
Reiterated
03/10/25
Piper Sandler
$11→$12
Hold
-53.56%
Downside
Reiterated
11/07/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$27
Hold
4.49%
Upside
Reiterated
05/16/25
Pacira Pharmaceuticals shows potential with strong gross margins and positive earnings call guidance. However, profitability challenges and high leverage are significant risks. Technical indicators suggest moderate short-term momentum, but valuation remains a concern with a negative P/E ratio. Strategic initiatives could drive growth, but operational efficiencies need improvement.
J.P. Morgan
$21→$24
Sell
-7.12%
Downside
Reiterated
05/16/25
Truist Financial
―
Hold
―
Reiterated
05/09/25
Needham
$32→$30
Buy
16.10%
Upside
Reiterated
05/09/25
RBC Capital
$26
Hold
0.62%
Upside
Reiterated
05/08/25
Jefferies
$44
Buy
70.28%
Upside
Reiterated
04/08/25
H.C. Wainwright
$48→$65
Buy
151.55%
Upside
Reiterated
04/08/25
Raymond James
―
Hold
―
Reiterated
04/08/25
Barclays
$24
Hold
-7.12%
Downside
Reiterated
03/10/25
Piper Sandler
$11→$12
Hold
-53.56%
Downside
Reiterated
11/07/24
Best Analysts Covering Pacira Pharmaceuticals
1 Month
xxx
Success Rate
18/42 ratings generated profit
Average Return
-0.30%
reiterated a xxx
rating 24 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 42.86% of your transactions generating a profit, with an average return of -0.30% per trade.
3 Months
xxx
Success Rate
20/41 ratings generated profit
Average Return
+1.95%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 48.78% of your transactions generating a profit, with an average return of +1.95% per trade.
1 Year
Success Rate
15/41 ratings generated profit
Average Return
-2.67%
reiterated a buy rating 2 months ago
Copying Oren Livnat's trades and holding each position for 1 Year would result in 36.59% of your transactions generating a profit, with an average return of -2.67% per trade.
2 Years
xxx
Success Rate
17/41 ratings generated profit
Average Return
-3.67%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 41.46% of your transactions generating a profit, with an average return of -3.67% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PCRX Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
3
3
2
3
2
Buy
2
2
2
2
2
Hold
8
8
9
8
7
Sell
3
3
2
1
1
Strong Sell
0
0
0
0
0
total
16
16
15
14
12
Each month's total comprises the sum of three months' worth of ratings.
PCRX Financial Forecast
PCRX Stock Forecast FAQ
What is PCRX’s average 12-month price target, according to analysts?
Based on analyst ratings, Pacira Pharmaceuticals’s 12-month average price target is 35.50.
What is PCRX’s upside potential, based on the analysts’ average price target?
Pacira Pharmaceuticals has 37.38% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PCRX a Buy, Sell or Hold?
Pacira Pharmaceuticals has a consensus rating of Hold which is based on 3 buy ratings, 4 hold ratings and 1 sell ratings.
What is Pacira Pharmaceuticals’s price target?
The average price target for Pacira Pharmaceuticals is 35.50. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $65.00 ,the lowest forecast is $24.00. The average price target represents 37.38% Increase from the current price of $25.84.
The highest analyst price target is $65.00 ,the lowest forecast is $24.00. The average price target represents 37.38% Increase from the current price of $25.84.
What do analysts say about Pacira Pharmaceuticals?
Pacira Pharmaceuticals’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of PCRX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.